Yijiao Xu

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Small Cell Lung Cancer

Oral Anticoagulants

Mycobacterium Tuberculosis

Top Venues

BMC pulmonary medicine

Health science reports

This page only lists publications with an associated author ORCID identifier.

Publications

Yijiao Xu, Qingwei Zhang, Zhisheng Chen, Shuwen Yang, Haiyan Chen, Xiong Xiao, Hongni Jiang
Impact of immune checkpoint inhibitors (ICIs) therapy on interferon-γ release assay (IGRA) and diagnostic value in non-small cell lung cancer (NSCLC) patients. BMC pulmonary medicine 24 (1) (2024)
Yijiao Xu, Qingwei Zhang, Zhisheng Chen, Shuwen Yang, Haiyan Chen, Xiong Xiao, Hongni Jiang
Impact of immune checkpoint inhibitors (ICIs) therapy on interferon-γ release assay (IGRA) and diagnostic value in non-small cell lung cancer (NSCLC) patients. BMC pulmonary medicine 24 (1) (2024)
Chang Cao, Yijiao Xu, Weiwen Jiang, Shujing Wu, Yun Shen, Xiaotong Xia, Lumin Wang, Huijun Zhang, Hongni Jiang, Xiaoyu Li, Xiaoye Li, Yan-Rong Ye
Nomogram for predicting bleeding events in nonvalvular atrial fibrillation patients receiving rivaroxaban: A retrospective study. Health science reports 7 (1) (2024)
Yijiao Xu, Qingwei Zhang, Zhisheng Chen, Shuwen Yang, Haiyan Chen, Xiong Xiao, Hongni Jiang
Impact of immune checkpoint inhibitors (ICIs) therapy on interferon-γ release assay (IGRA) and diagnostic value in non-small cell lung cancer (NSCLC) patients. BMC pulmonary medicine 24 (1) (2024)
Chang Cao, Yijiao Xu, Weiwen Jiang, Shujing Wu, Yun Shen, Xiaotong Xia, Lumin Wang, Huijun Zhang, Hongni Jiang, Xiaoyu Li, Xiaoye Li, Yan-Rong Ye
Nomogram for predicting bleeding events in nonvalvular atrial fibrillation patients receiving rivaroxaban: A retrospective study. Health science reports 7 (1) (2024)